Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sahreh Shabani, Zahra Rabiei & Hossein Amini-Khoei. (2020) Exploring the multifaceted neuroprotective actions of gallic acid: a review. International Journal of Food Properties 23:1, pages 736-752.
Read now
Read now
Declan Browne, Bernadette McGuinness, Jayne V Woodside & Gareth J McKay. (2019) Vitamin E and Alzheimer’s disease: what do we know so far?. Clinical Interventions in Aging 14, pages 1303-1317.
Read now
Read now
Yen-Ni Hung, Zbigniew Kadziola, Alan JM Brnabic, Ju-Fen Yeh, Jong-Ling Fuh, Jen-Ping Hwang & William Montgomery. (2016) The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database. ClinicoEconomics and Outcomes Research 8, pages 387-395.
Read now
Read now
Liandong Zhao, Ying Zhao, Qi Wan & Haijun Zhang. (2015) Urinary kallidinogenase for the treatment of cerebral arterial stenosis. Drug Design, Development and Therapy 9, pages 5595-5600.
Read now
Read now
Articles from other publishers (14)
Catherine R. Jutzeler, Lucie Bourguignon, Bobo Tong, Elias Ronca, Eric Bailey, Noam Y. Harel, Fred Geisler, Adam R. Ferguson, Brian K. Kwon, Jacquelyn J. Cragg, Lukas Grassner & John L. K. Kramer. (2023) Pharmacological management of acute spinal cord injury: a longitudinal multi-cohort observational study. Scientific Reports 13:1.
Crossref
Crossref
Shuhuan Peng, Fangyi Li, Kuo Yu, Fengshu Zhou, Heshui Yu, Hui Liu, Jialiang Guo, Guoqiang Li, Chunhua Wang, Xiaohui Yan & Zheng Li. (2022) Integrating transcriptome and chemical analyses to reveal the anti-Alzheimer’s disease components in Verbena officinalis Linn. Frontiers in Plant Science 13.
Crossref
Crossref
Zeinab Breijyeh & Rafik Karaman. (2020) Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules 25:24, pages 5789.
Crossref
Crossref
Tao Hu, Shan Li, Wen-Qi Liang, Shan-Shan Li, Min-Nan Lu, Bo Chen, Li Zhang, Rui Mao, Wan-Hai Ding, Wen-Wei Gao, Shi-Wen Chen, Yan-Bin XiYang, Jie Zhang & Xu-Yang Wang. (2020) Notoginsenoside R1–Induced Neuronal Repair in Models of Alzheimer Disease Is Associated With an Alteration in Neuronal Hyperexcitability, Which Is Regulated by Nav. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Agnieszka Zagórska & Anna Jaromin. (2020) Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy. Molecules 25:15, pages 3337.
Crossref
Crossref
Ali Chaari, Christine Fahy, Alexandre Chevillot-Biraud & Mohamed Rholam. (2019) Investigating the effects of different natural molecules on the structure and oligomerization propensity of hen egg-white lysozyme. International Journal of Biological Macromolecules 134, pages 189-201.
Crossref
Crossref
Janaina Balthazar, Natalia Mendes Schöwe, Gabriela Cabett Cipolli, Hudson Sousa Buck & Tania Araujo Viel. (2018) Enriched Environment Significantly Reduced Senile Plaques in a Transgenic Mice Model of Alzheimer’s Disease, Improving Memory. Frontiers in Aging Neuroscience 10.
Crossref
Crossref
Lucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, Rob Howard, John T O’Brien, Gail Mountain, Sube Banerjee, Bob Woods, Robert Perneczky, Louise Lafortune, Charlotte Roberts, Jenny McCleery, James Pickett, Frances Bunn, David Challis, Georgina Charlesworth, Katie Featherstone, Chris Fox, Claire Goodman, Roy Jones, Sallie Lamb, Esme Moniz-Cook, Justine Schneider, Sasha Shepperd, Claire Surr, Jo Thompson-Coon, Clive Ballard, Carol Brayne, Orlaith Burke, Alistair Burns, Linda Clare, Peter Garrard, Patrick Kehoe, Peter Passmore, Clive Holmes, Ian Maidment, Fliss Murtagh, Louise Robinson & Gill Livingston. (2017) Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technology Assessment 21:26, pages 1-192.
Crossref
Crossref
Shmma Quraishe, Megan Sealey, Louise Cranfield & Amritpal Mudher. (2016) Microtubule stabilising peptides rescue tau phenotypes in-vivo. Scientific Reports 6:1.
Crossref
Crossref
Manju Tembhre. (2016) Assessment of Acetylcholinestrase Inhibiton by Bacopa Monneiri and Acephate in Hippocampus of Chick Brain for Impediment of Alzheimer’s Disease. Pharmacy & Pharmacology International Journal 4:5.
Crossref
Crossref
Lieven D. Declercq, Rik Vandenberghe, Koen Van Laere, Alfons Verbruggen & Guy Bormans. (2016) Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT. Frontiers in Pharmacology 7.
Crossref
Crossref
Yoshitaka Nagai & Eiko N. Minakawa. 2015. Neurodegenerative Disorders as Systemic Diseases. Neurodegenerative Disorders as Systemic Diseases
183
216
.
Justin Davis & Robin Couch. (2014) Strategizing the Development of Alzheimer’s Therapeutics. Advances in Alzheimer's Disease 03:03, pages 107-127.
Crossref
Crossref
Bernd Saletu, Amit Garg & Ahsan Shoeb. (2014) Safety of Nicergoline as an Agent for Management of Cognitive Function Disorders. BioMed Research International 2014, pages 1-6.
Crossref
Crossref